Asylia Therapeutics
Houston, US · Founded 2019 · Delaware corporation
Founders & leadership
JK
Joseph KekstNamed on SEC filing
EE
Elan EzicksonNamed on SEC filing
JG
Jeno GyurisNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$8.2M disclosed across 1 round · 2021
▶$8.2MraisedMar 2021 · 1 investors · BiotechnologyRule 506(b)
▶$8.2MraisedMar 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph KekstDirector
- Elan EzicksonExecutive Officer, Director
- Jeno GyurisExecutive Officer, Director
- Offering amount
- $16.2M
- Amount sold
- $8.2M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Asylia Therapeutics raised?
- Asylia Therapeutics has disclosed $8.2M raised across 1 round.
- Where is Asylia Therapeutics headquartered?
- Asylia Therapeutics is headquartered in Houston, US.